Related Experiment Video
Updated: May 31, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Challenges of translating basic research into therapeutics: resveratrol as an example
James M Smoliga1, Ole Vang, Joseph A Baur
1Department of Health and Physical Education, Human Physiology Laboratory, Marywood University, Scranton, Pennsylvania, USA.
Summary
Resveratrol, a natural compound, faces significant hurdles in human studies due to pharmacokinetic and mechanistic complexities. Further research is needed to clarify its potential health benefits and establish effective therapeutic applications.
Area of Science:
- Pharmacology and Natural Product Chemistry
- Translational Medicine
- Drug Development
Background:
- Numerous natural compounds show promise in preclinical studies for various diseases.
- However, most fail to progress to human clinical trials due to development challenges.
- Resveratrol serves as a case study for these difficulties, particularly in understanding its effects in humans.
Purpose of the Study:
- To highlight the challenges in evaluating natural compounds like resveratrol in humans.
- To discuss pharmacokinetic, side effect, and mechanism of action determination difficulties.
- To explore new paradigms for efficient evaluation of natural products.
Main Methods:
- Analysis of existing literature on resveratrol's human and animal studies.
- Discussion of intellectual property and commercialization issues impacting natural product research.
- Proposal of new methodologies including molecular modeling, large-scale screening, and data synthesis.
Main Results:
- Despite extensive research, human data on resveratrol's effects remain sparse and inconclusive.
- Commercialization strategies, such as proprietary blends, hinder comparative analysis.
- Natural compounds like resveratrol likely possess multiple targets with complex interactions.
Conclusions:
- Significant obstacles exist in translating promising natural compounds into proven human therapies.
- Development of novel research paradigms is crucial for efficient and accurate assessment.
- Further well-designed studies are warranted to investigate resveratrol's therapeutic potential in humans.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...